From: When do patient reported quality of life indicators become prognostic in breast cancer?
Trial Number | VI | VII | VIII | IX | 13 | 14 | 15 | Total |
---|---|---|---|---|---|---|---|---|
N | ||||||||
No relapse | 568 | 380 | 789 | 1118 | 704 | 495 | 136 | 4190 |
Local recurrence | 167 | 102 | 88 | 84 | 92 | 72 | 20 | 625 |
Contralateral breast cancer | 71 | 36 | 42 | 57 | 40 | 26 | 6 | 278 |
Regional nodal metastasis | 106 | 81 | 16 | 18 | 59 | 42 | 18 | 340 |
Distant soft tissue / nodal metastasis | 37 | 26 | 13 | 11 | 11 | 9 | 11 | 118 |
Distant bone metastasis | 207 | 169 | 42 | 50 | 132 | 91 | 41 | 732 |
Distant visceral metastasis | 260 | 242 | 80 | 119 | 177 | 177 | 99 | 1154 |
Second breast cancer primary | 48 | 89 | 30 | 108 | 22 | 42 | 7 | 346 |
Death without recurrence | 10 | 76 | 7 | 102 | 9 | 14 | 5 | 223 |
Unknown | 1 | 11 | 2 | 2 | 0 | 1 | 1 | 18 |
Total | 1475 | 1212 | 1109 | 1669 | 1246 | 969 | 344 | 8024 |